A significant advance in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This vital tumor inhibitor protein is frequently inactivated in many kinds of cancer, resulting uncontrolled https://bookmarkssocial.com/story21869561/nanobodies-reactivate-p53-the-new-approach-for-tumor-management